Synthetic cannabinoids pharmaceutical market — the FDA-approved synthetic cannabinoid medicines including dronabinol (synthetic THC, Marinol), nabilone (synthetic cannabinoid, Cesamet), and the emerging pipeline of synthetic cannabinoid receptor agonists and modulators for therapeutic applications — represent the legitimate pharmaceutical market within the broader synthetic...
A major 2026 trend in the synthetic cannabinoid space is the integration of artificial intelligence to design entirely new molecules that target specific pain receptors without psychoactive side effects. In 2026, biotech firms are using AI to screen thousands of synthetic analogs, identifying compounds that could treat epilepsy or Parkinson’s disease more effectively than current natural...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
คลิกดาวน์โหลด
china 
thai
English
French
Spanish
Portuguese
Italiano
Romaian
Portuguese (Brazil)